Investor FAQs

Investor FAQs

Show All
When was the Company founded/incorporated?

EnteroMedics was incorporated in December 2002.

Where is the Company incorporated?

We were incorporated in Minnesota in December 2002 under the name Beta Medical, Inc. In 2003, we changed our name to EnteroMedics Inc. and in 2004 we reincorporated in Delaware. In October 2017, we changed our name to ReShape Lifesciences, Inc.

Where are the Company offices located?

Our principal executive offices are located at 1001 Calle Amanecer, San Clemente, CA 92673, and our telephone number is (949) 429-6680.

When did the Company go public?

The Company completed its initial public offering on November 15, 2007.

Where is the Company traded?

EnteroMedics trades on NASDAQ under the symbol RSLS.

When does the Company fiscal year end?

The Company operates with a December 31 fiscal year end.

How can I get a copy of the Company's financial statements?

Annual Reports, Form 10-Ks, Form 10-Qs and other reports are posted to this website as soon as they are filed with the SEC.

How can I buy shares of the Company?

Contact a licensed stockbroker to purchase shares in our company.

What industry is the Company in?

The Company is a medical technology company focused on the design, development and communication of transformative technology to treat obesity and metabolic diseases.

Does the Company pay dividends?

The Company has not historically paid dividends.

Who is the Company's transfer agent?

Wells Fargo Bank National Association

What is a transfer agent?

Equiniti (formerly Wells Fargo Shareowner Services)

What is EnteroMedics's CUSIP number?

761123108

Who are EnteroMedics' independent accountants?

Deloitte & Touche LLP (Minneapolis, MN)